Major Infectious Diseases

Major Infectious Diseases

Jim Pridgeon, University of Washington School of Medicine
  • The decline of the vaccine-preventable diseases has contributed to a recognition of the potential for using vaccines to prevent other infectious diseases.

  • Emerging pandemic viral infections remain a constant threat, many entering the human population from contact with animals. Relatively few antiviral drugs have been developed to treat these emerging infections. Therefore, the most important intervention is to break the chain of transmission. 

     

  • Integration of HIV and TB diagnosis and management must be done in ways that are safe, where risk of transmission can be mitigated.  This offers opportunities for efficiently managing infections. 

  • Infectious disease control involves not only prevention of transmission and spread of infectious disease at the population and individual levels, but also effective treatment and cure of infectious diseases in individuals.

 

"This third edition of the Disease Control Priorities comes at a pivotal moment for infectious disease control and research. Its chapters clearly demonstrate that, despite the remarkable progress, infectious diseases remain a major threat to health worldwide—particularly in South Asia and Sub-Saharan Africa—but that an increasing range of highly cost-effective interventions is available. As this volume amply illustrates, innovations in the prevention, diagnosis, and treatment of infectious diseases have been impressive."

Read the complete foreword:  HTML | PDF

HIV Prevalence Among Women

 

 

Global HIV Prevalence Among Women, Ages 15 – 24 Years, 2014

 Source: World Bank 2014; Actualitix

Infectious Disease Deaths

 

 

GBD 2013 Mortality and Causes of Death Collaborators. 2015. “Global, Regional, and National Age-Sex Specific All-Cause and Cause-Specific Mortality for 240 Causes of Death, 1990–2013: A Systematic Analysis for the Global Burden of Disease Study 2013.” The Lancet 385 (9963): 117–71.

UNAIDS (Joint United Nations Program on HIV/AIDS). 2015. How AIDS Changed Everything. MDG 6: 15 Years, 15 Lessons of Hope from the AIDS Response. Geneva: UNAIDS.

WHO. 2015. Global Tuberculosis Report 2015. Geneva: WHO.

News and Events

Dr. Corey Casper - lead author for the DCP3 chapter on HIV co-morbidities, and Chief Medical Officer at the Infectious Disease Research Institute (IDRI) - recently served as a guest columnist for Life Science Leader, writing about IDRI's increased commitment to expand its portfolio of effective...
DCP3 Advisory Committee member Dr. Glenda Gray, has been named one of TIME magazine's 100 most influential people of 2017. Lauded for her work as a pioneer in HIV research in South Africa- particularly mother-to-child transmission - Dr. Gray is currently conducting an HIV-vaccine study and is...
DCP3 Advisory Committee member and chapter author, Dr. Patricia (Patty) Garcia, has recently been named Peru's new Minister of Health. Dr. Garcia is also an affiliate professor at the University of Washington's School of Public Health.

Volume Editors

King Holmes

King Holmes
University of Washington Department of Global Health

Stefano Bertozzi

Stefano Bertozzi
University of California, Berkeley School of Public Health

Barry R. Bloom

Barry R. Bloom
Harvard T.H. Chan School of Public Health

Prabhat Jha

Prabhat Jha
Centre for Global Health Research, Toronto

Brie Adderley

Volume Coordinator
Brie Adderley
University of Washington, Dept. of Global Health